Product Manual

_________________________________________________________________________________
SofiaInfluenzaA+BFIA
 Page16of25
Table6
PerformanceComparedtoCultureforEachSampleTypebyAgeGroupforInfluenzaB
NasalSwabs NasopharyngealSwabs NasopharyngealAspirate/Wash
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
AllAges
89%(100/112)
(95%CI=82%94%)
96%(530/553)
(95%CI=94%97%)
90%(101/112)
(95%CI=83%95%)
97%(602/621)
(95%CI=95%98%)
88%(46/52)
(95%CI=77%95%)
96%(575/597)
(95%CI=94%98%)
<6years
90%(35/39)
(95%CI=76%97%)
96%(238/247)
(95%CI=93%98%)
87%(54/62)
(95%CI=76%94%)
97%(455/471)
(95%CI=95%98%)
87%(39/45)
(95%CI=73%94%)
96%(572/594)
(95%CI=94%98%)
6to21
years
92%(56/61)
(95%CI=82%97%)
95%(187/196)
(95%CI=91%98%)
94%(45/48)
(95%CI=83%98%)
98%(130/132)
(95%CI=94%100%)
100%(7/7)
(95%CI=60%100%)
100%(3/3)
(95%CI=38%100%)
22to59
years
73%(8/11)
(95%CI=43%91%)
97%(89/92)
(95%CI=90%99%)
100%(2/2)
(95%CI=29%100%)
94%(16/17)
(95%CI=71%100%)
N/A(0/0) N/A(0/0)
60Years
andup
100%(1/1)
(95%CI=17%100%)
89%(16/18)
(95%CI=66%98%)
N/A(0/0)
100%(1/1)
(95%CI=17%100%)
N/A(0/0) N/A(0/0)
ReproducibilityStudies
ThereproducibilityoftheSofiaInfluenzaA+BFIAwasevaluatedatthreedifferentlaboratories,oneofwhich
was Quidel. Two different operators at each site tested a series of coded, contrived samples, prepared in
negativeclini cal matrix,rangingfrom lownegativetomoderatepositive influenzaAand influenzaB. Testing
occurred on 5 different days spanning over approximately a 2w
eek period. Theinterlaboratory agreement
(Table 7) for negative samples was 94%100% and 98%100% for positive samples. The intra laboratory
agreement(Table8)forallsamplesrangedfrom98%99%.
Table7
SofiaInfluenzaA+BReproducibilityStudyInterLaboratoryAgreement
Lab
oratory
Site
Neg
(novirus)
FluA
HighNeg
(C
5
)
FluA
LowPos(C
95
)
FluA
ModPos
(C
3X
)
FluB
HighNeg
(C
5
)
FluB
LowPos
(C
95
)
FluB
ModPos
(C
3X
)
1 30/30 29/30 30/30 30/30 28/30 29/30 30/30
2 30/30 29/30 30/30 30/30 30/30 29/30 30/30
3 30/30 30/30 30/30 30/30 27/30 30/30 30/30
Total 90/90 88/90 90/90 90/90 85/90 88/90 90/90
%Overall
Agreement
with
Expected
Result
(95%CI)
100%
(95%100%)
98%
(92%100%)
100%
(95%100%)
100%
(95%100%)
94%
(87%98%)
98%
(92%100%)
100%
(95%100%)